Managing Director
-Pappas Capital
City: Durham, NC
Country: United States
Asset Class: Venture Capital
Preferred Stages: Seed, Series A, Series B
Preferred Sectors: Life sciences. Primarily biopharma and opportunistically medtech, diagnostics, therapeutic-enabling technologies, and agtech.
Preferred Geos: Primarily US. Selectively in Canada, Asia (e.g., Singapore), Europe.
Portfolio Link: View Portfolio
Board Postions: Horizon Quantum Computing (Observer), VFlowTech (Observer). Led Pappas investments in Us2.ai, NuProbe, RoboCT, Aktis Oncology, EarthOptics.
Elizabeth is a Managing Director at Pappas Capital where she works across funds, including Pappas Ventures and Asia Innovation Ventures. She led the firm’s expansion into Asia and investments in Horizon Quantum Computing, NuProbe, RoboCT, Us2.ai, and VFlowTech.
Prior to Pappas, Elizabeth invested in digital health and healthcare technology companies at Echo Health Ventures and its predecessor, Mosaic Health Solutions, both subsidiaries of Blue Cross NC, and had a variety of cross-functional responsibilities at Chimerix (NASDAQ: CMRX), including in the company’s IPO. She has a BA from the University of North Carolina at Chapel Hill and an MBA from UNC’s Kenan-Flagler Business School.